The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
White Papers
Incorporating the targets for transformation set by the leader of our organization including unjustified variation, fragmentation of care-giv
White Papers
This white paper was written as a recap of the AHRMM15 Cost, Quality, and Outcomes (CQO) Summit, held in August of 2015.
White Papers
The purpose of this paper is to share lessons learned and successes in contract management.
White Papers
White Papers
This paper provides a case-study on what Banner has done to implement and continuously improve this initiative.
White Papers
A well-conceived strategic sourcing program starts with an analysis of the total spend or operating expenses of the organization utilizing an